Abdel Rahman GAN, Mohamed AF
Authors not listed · 2025
Database error: this pharmaceutical study contains no EMF research and shouldn't influence EMF health decisions.
Plain English Summary
This study appears to be misclassified in an EMF database, as it actually examined Factor XIa inhibitor drugs for preventing blood clots in atrial fibrillation patients. Researchers analyzed three clinical trials comparing these new anticoagulant medications to standard blood thinners. The study found no EMF-related health effects because it wasn't an EMF study at all.
Why This Matters
This appears to be a database classification error. The study examines pharmaceutical anticoagulants for heart rhythm disorders, not electromagnetic field exposures. While such mix-ups might seem trivial, they highlight a broader issue in EMF research: the importance of rigorous study categorization and peer review. When genuine EMF health studies get lost among unrelated research, it becomes harder for both scientists and the public to access the real evidence about electromagnetic exposures. This kind of database contamination can undermine confidence in EMF research databases and make it more difficult to identify legitimate patterns in the scientific literature. What this means for you is the need to verify that EMF studies actually involve electromagnetic field exposures before drawing any health conclusions.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{abdel_rahman_gan_mohamed_af_ce3945,
author = {Unknown},
title = {Abdel Rahman GAN, Mohamed AF},
year = {2025},
doi = {10.1161/circ.152.suppl_3.4361654},
}